-
effectivehealthcare.ahrq.gov/products/cad-women-treatment/research
-
effectivehealthcare.ahrq.gov/products/ischemic-stroke-treatment/research-protocol
-
effectivehealthcare.ahrq.gov/products/cad-pci-bypass/research
-
effectivehealthcare.ahrq.gov/products/acs-depression/research-review-final
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/uterine-fibroids_research-protocol.pdf
March 01, 2016 - treatment effectiveness differ by patient or fibroid characteristics
(e.g., age, race/ethnicity; symptoms; vascular … characteristics (e.g., age; race/ethnicity; symptoms; menopausal status; imaging
characteristics; vascular
-
effectivehealthcare.ahrq.gov/products/data-points-series/series-overview
-
effectivehealthcare.ahrq.gov/products/diabetic-neuropathy/research-protocol
-
effectivehealthcare.ahrq.gov/products/plasma-cell-dyscrasias-sflc-assay/research
-
effectivehealthcare.ahrq.gov/products/thromboembolism-update/research-protocol
-
effectivehealthcare.ahrq.gov/products/cad-pci-bypass-future/research
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
January 01, 2016 - The total incidence of deaths from vascular or unknown
causes, nonfatal myocardial infarctions, and … nonfatal cerebrovascular accidents,
which are possible effects from systemic vascular endothelial … The incidence of serious adverse events potentially related to systemic vascular
endothelial growth … Vascular endothelial growth factor A. In:
GeneCards [internet]. … Clinical policy bulletin: vascular
endothelial growth factor inhibitors for ocular
neovascularization
-
effectivehealthcare.ahrq.gov/products/adhd-heart-disease-children/research
-
effectivehealthcare.ahrq.gov/products/migraine-emergency/research-protocol
-
effectivehealthcare.ahrq.gov/products/blood-clots-hip-knee-surgery/research-protocol
-
effectivehealthcare.ahrq.gov/products/mental-illness-heart/research-protocol
-
effectivehealthcare.ahrq.gov/products/bariatric-surgery/research
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-table-e5-2022-update_0.xlsx
January 01, 2022 - 0.32 to 0.71)
Psychiatric disorders: 4.2% (14/337) vs. 14.8% (50/337), RR 0.28 (95% CI 0.16 to 0.50)
Vascular
-
effectivehealthcare.ahrq.gov/products/thromboembolism-update/research-2017
-
effectivehealthcare.ahrq.gov/products/blood-clots-hip-knee-surgery/research
-
effectivehealthcare.ahrq.gov/products/diabetes-foot-ulcer-amputation-incidence/research